228 related articles for article (PubMed ID: 10918490)
1. Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression.
McCart JA; Puhlmann M; Lee J; Hu Y; Libutti SK; Alexander HR; Bartlett DL
Gene Ther; 2000 Jul; 7(14):1217-23. PubMed ID: 10918490
[TBL] [Abstract][Full Text] [Related]
2. In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase.
Chung-Faye GA; Chen MJ; Green NK; Burton A; Anderson D; Mautner V; Searle PF; Kerr DJ
Gene Ther; 2001 Oct; 8(20):1547-54. PubMed ID: 11704815
[TBL] [Abstract][Full Text] [Related]
3. Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in mice.
Gnant MF; Puhlmann M; Alexander HR; Bartlett DL
Cancer Res; 1999 Jul; 59(14):3396-403. PubMed ID: 10416601
[TBL] [Abstract][Full Text] [Related]
4. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
[TBL] [Abstract][Full Text] [Related]
5. Fractionated radiation therapy in combination with adenoviral delivery of the cytosine deaminase gene and 5-fluorocytosine enhances cytotoxic and antitumor effects in human colorectal and cholangiocarcinoma models.
Stackhouse MA; Pederson LC; Grizzle WE; Curiel DT; Gebert J; Haack K; Vickers SM; Mayo MS; Buchsbaum DJ
Gene Ther; 2000 Jun; 7(12):1019-26. PubMed ID: 10871750
[TBL] [Abstract][Full Text] [Related]
6. Enzyme/prodrug gene therapy for human colon cancer cells using adenovirus-mediated transfer of the Escherichia coli cytosine deaminase gene driven by a CAG promoter associated with 5-fluorocytosine administration.
Koyama F; Sawada H; Fujii H; Hirao T; Ueno M; Hamada H; Nakano H
J Exp Clin Cancer Res; 2000 Mar; 19(1):75-80. PubMed ID: 10840940
[TBL] [Abstract][Full Text] [Related]
7. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine.
Koyama F; Sawada H; Hirao T; Fujii H; Hamada H; Nakano H
Cancer Gene Ther; 2000 Jul; 7(7):1015-22. PubMed ID: 10917204
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated GM-CSF gene and cytosine deaminase gene transfer followed by 5-fluorocytosine administration elicit more potent antitumor response in tumor-bearing mice.
Cao X; Ju DW; Tao Q; Wang J; Wan T; Wang BM; Zhang W; Hamada H
Gene Ther; 1998 Aug; 5(8):1130-6. PubMed ID: 10326037
[TBL] [Abstract][Full Text] [Related]
9. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
[TBL] [Abstract][Full Text] [Related]
10. Regional 'pro-drug' gene therapy: intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma.
Topf N; Worgall S; Hackett NR; Crystal RG
Gene Ther; 1998 Apr; 5(4):507-13. PubMed ID: 9614575
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer-specific expression of the Candida albicans cytosine deaminase gene using a transcriptional targeting approach.
Anderson LM; Krotz S; Weitzman SA; Thimmapaya B
Cancer Gene Ther; 2000 Jun; 7(6):845-52. PubMed ID: 10880014
[TBL] [Abstract][Full Text] [Related]
12. Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus.
Foloppe J; Kintz J; Futin N; Findeli A; Cordier P; Schlesinger Y; Hoffmann C; Tosch C; Balloul JM; Erbs P
Gene Ther; 2008 Oct; 15(20):1361-71. PubMed ID: 18480846
[TBL] [Abstract][Full Text] [Related]
13. Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes.
McCart JA; Ward JM; Lee J; Hu Y; Alexander HR; Libutti SK; Moss B; Bartlett DL
Cancer Res; 2001 Dec; 61(24):8751-7. PubMed ID: 11751395
[TBL] [Abstract][Full Text] [Related]
14. Multimodality therapy with a replication-conditional herpes simplex virus 1 mutant that expresses yeast cytosine deaminase for intratumoral conversion of 5-fluorocytosine to 5-fluorouracil.
Nakamura H; Mullen JT; Chandrasekhar S; Pawlik TM; Yoon SS; Tanabe KK
Cancer Res; 2001 Jul; 61(14):5447-52. PubMed ID: 11454690
[TBL] [Abstract][Full Text] [Related]
15. Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine.
Haberkorn U; Oberdorfer F; Gebert J; Morr I; Haack K; Weber K; Lindauer M; van Kaick G; Schackert HK
J Nucl Med; 1996 Jan; 37(1):87-94. PubMed ID: 8544010
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
Akbulut H; Zhang L; Tang Y; Deisseroth A
Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
[TBL] [Abstract][Full Text] [Related]
17. In vivo adenoviral-mediated gene transfer in the treatment of pancreatic cancer.
Evoy D; Hirschowitz EA; Naama HA; Li XK; Crystal RG; Daly JM; Lieberman MD
J Surg Res; 1997 Apr; 69(1):226-31. PubMed ID: 9202675
[TBL] [Abstract][Full Text] [Related]
18. 5-Fluorocytosine increases the toxicity of Wnt-targeting replicating adenoviruses that express cytosine deaminase as a late gene.
Fuerer C; Iggo R
Gene Ther; 2004 Jan; 11(2):142-51. PubMed ID: 14712298
[TBL] [Abstract][Full Text] [Related]
19. Improvement of carcinoembryonic antigen-specific prodrug gene therapy for experimental colon cancer.
Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Ojima T; Yamaue H
Surgery; 2003 Mar; 133(3):309-17. PubMed ID: 12660644
[TBL] [Abstract][Full Text] [Related]
20. 5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory.
Consalvo M; Mullen CA; Modesti A; Musiani P; Allione A; Cavallo F; Giovarelli M; Forni G
J Immunol; 1995 May; 154(10):5302-12. PubMed ID: 7730633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
